| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46e8c10c6fe79854db8512f9e730f069 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74 |
| filingDate |
2001-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e52bc3047f7ae136fc0afbfa8d6622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dcd1b28a27b0c7499ebe123dcd2403c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19114c90947d77d13496eeb376baec9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_975c8e2fbac79adb0d14ac00bc42cd53 |
| publicationDate |
2003-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2828403-A1 |
| titleOfInvention |
USE OF HLA CLASS 1 SOLUBLE MOLECULES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR INHIBITING ANGIOGENESIS |
| abstract |
The subject of the present invention is the use of a soluble HLA class 1 molecule or of a nucleic acid molecule comprising a polynucleotide sequence coding for a soluble HLA class 1 molecule for the preparation of pharmaceutical compositions intended to inhibit the angiogenesis or to detect angiogenic sites. The invention relates more particularly to the use of the molecules HLA-G1s or HLA-B7s for the treatment of pathologies including cancer, diabetic retinopathies, rheumatoid arthritis, chronic rejection of transplants such as the cornea or the kidney or the acute rejection observed in xenotransplants, angiomas, angiosarcomas, in particular Castelman's disease or Kaposi's sarcoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2934498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010012912-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010012912-A3 |
| priorityDate |
2001-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |